We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.57B
AUM Growth
+$643M
(+9.3%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.11% |
| 2 | Industrials | 11.84% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Technology | 10.61% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Green Plains
GPRE
$1.19B
| $9.48M | 0.13% |
+382,551
| New | +$11.5M |
|
|
QIHU
202
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $9.46M | 0.12% |
+165,154
| New | +$10.9M |
|
203
Banco Bradesco
BBD
$37.9B
| $9.43M | 0.12% |
1,799,698
-398,953
| -18% | -$2.23M |
|
204
NetApp
NTAP
$37.4B
| $9.42M | 0.12% |
227,169
-129,053
| -36% | -$5.36M |
|
|
PLL
205
DELISTED
PALL CORP
PLL
| $9.39M | 0.12% |
92,767
-53,233
| -36% | -$4.91M |
|
206
Freeport-McMoran
FCX
$96.7B
| $9.11M | 0.12% |
390,137
+377,929
| +3,096% | +$10.4M |
|
|
UMPQ
207
DELISTED
Umpqua Holdings Corp
UMPQ
| $9.1M | 0.12% |
534,865
+17,797
| +3% | +$301K |
|
208
Kimberly-Clark
KMB
$37B
| $9.06M | 0.12% |
78,459
+11,701
| +18% | +$1.3M |
|
209
Groupon
GRPN
$1.04B
| $8.9M | 0.12% |
53,883
+50,148
| +1,343% | +$7.12M |
|
210
Graphic Packaging
GPK
$3.52B
| $8.86M | 0.12% |
650,195
-365,728
| -36% | -$4.53M |
|
211
Clorox
CLX
$12.7B
| $8.82M | 0.12% |
+84,642
| New | +$8.46M |
|
212
Oceaneering
OII
$5.02B
| $8.77M | 0.12% |
+149,091
| New | +$9.57M |
|
|
AKRX
213
DELISTED
Akorn Inc
AKRX
| $8.72M | 0.12% |
240,985
+138,102
| +134% | +$5.33M |
|
214
Arch Capital
ACGL
$33.9B
| $8.67M | 0.11% |
+439,947
| New | +$8.34M |
|
215
McKesson
MCK
$97.2B
| $8.62M | 0.11% |
41,537
-17,305
| -29% | -$3.52M |
|
216
SBA Communications
SBAC
$19.9B
| $8.6M | 0.11% |
+77,598
| New | +$8.73M |
|
217
Gentex
GNTX
$5.14B
| $8.58M | 0.11% |
475,144
+224,818
| +90% | +$3.74M |
|
218
Danaher
DHR
$137B
| $8.53M | 0.11% |
+148,118
| New | +$8.03M |
|
219
Western Digital
WDC
$189B
| $8.49M | 0.11% |
101,486
-303,742
| -75% | -$22.9M |
|
220
CVS Health
CVS
$133B
| $8.39M | 0.11% |
87,132
-241,803
| -74% | -$21.3M |
|
|
COV
221
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $8.39M | 0.11% |
82,025
+2,685
| +3% | +$258K |
|
222
Grand Canyon Education
LOPE
$3.93B
| $8.35M | 0.11% |
+178,839
| New | +$7.98M |
|
223
Zimmer Biomet
ZBH
$18.5B
| $8.32M | 0.11% |
75,523
+72,875
| +2,752% | +$7.68M |
|
|
TRW
224
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $8.21M | 0.11% |
79,802
+61,018
| +325% | +$6.23M |
|
225
TIM SA
TIMB
$8.74B
| $8.2M | 0.11% |
369,152
+99,026
| +37% | +$2.35M |
|
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.